News | LSHTM

Close

LSHTM

Found 0 results for your search. Showing 20 to 0.

No results could be found for your search.

Close

News

Timothy Powell-Jackson and Giulia Greco

New Centre Co-Directors Announced

Thursday 16 March 2023

Aris Angelis said: "Governments and drug authorities need to re-think policy and regulatory incentives for valuable biopharmaceutical innovation at affordable pricing to ensure equitable access."

Pharmaceutical companies can develop more innovative and affordable medicines by refocusing their spending but government intervention is needed

Thursday 16 February 2023

GHECO SLOs: (left to right) Leonard, Nimali and Marika

Meet the 2022/23 GHECO Student Liaison Officers

Tuesday 7 February 2023

Rebecca Clark said: "These results can be used to support scaling up global investment in TB vaccine research and development to prevent millions of deaths worldwide."

Tuberculosis vaccination could be highly impactful and cost-effective in most low- and middle-income countries

Thursday 26 January 2023

Nasser Fardousi

Researcher in Focus: Nasser Fardousi

Monday 24 October 2022

Darius Erlangga

Researcher in Focus: Darius Erlangga

Monday 24 October 2022

Dr Ian Ross said: "If people tell us they want better toilets to feel safer and have more privacy, we should be measuring which interventions improve those outcomes the most."

Improved toilets have positive impacts on quality of life, new measure shows

Wednesday 5 October 2022

Dr Aris Angelis says: "Governments and public funders of medical research should safeguard the affordable and equitable access to COVID-19 interventions."

Public sector funding instrumental in the development of COVID-19 vaccines

Wednesday 17 August 2022

Nouria Brikci

Researcher in Focus: Nouria Brikci

Wednesday 15 June 2022

Stephen Lagony

Researcher in Focus: Stephen Lagony

Wednesday 15 June 2022

Dr Yang Liu said: “For African countries with large proportions of their population unvaccinated a year after the first COVID-19 vaccine was licensed, vaccination programmes can still provide health benefits and be cost-effective. Cost per dose is an important determinant of the latter.”

Earlier rollout of COVID-19 vaccination programmes cost-effective and could deliver greater health benefits

Monday 16 May 2022

Dr Catherine Pitt, said, "The economic results are very exciting. I hope that policy makers will consider both the substantial health gains and reductions in malaria treatment costs when weighing up the value of investing in more expensive – but ultimately more effective and efficient – vector control tools, such as PBO nets and chlorfenapyr nets."

No flight, no bite - 'Mosquito grounding' bed net nearly halves malaria infection in Tanzanian children

Thursday 31 March 2022